Clinical Trial Update: Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin plus prednisolone (Ox-P) in patients with relapsed or refractory marginal zone lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marginal Zone Lymphoma

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Dong-A University Hospital | Conditions: B-cell Lymphomas | Phase 2 | Status: COMPLETED